Showing results (221-230 of 266) with videos related to
Sort By:
Pageof 27
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 30, 2010
Intradermal vaccinations with RNA coding for TAA generate CD8+ and CD4+ immune responses and induce clinical benefit in vaccinated patientsSusanne M Rittig, Maik Haentschel, Katrin J Weimer, et al.Nature Communications|November 26, 2025
NLRP3-induced systemic inflammation controls the development of JAK2V617F mutant myeloproliferative neoplasmsRuth-Miriam Koerber, Calvin Krollmann, Kevin Cieslak, et al.Cancer Biology & Therapy|July 20, 2011
Cyclin-dependent kinase inhibitor Dinaciclib (SCH727965) inhibits pancreatic cancer growth and progression in murine xenograft modelsGeorg Feldmann, Anjali Mishra, Savita Bisht, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|March 24, 2007
Platelets recruit human dendritic cells via Mac-1/JAM-C interaction and modulate dendritic cell function in vitroHarald F Langer, Karin Daub, Gregor Braun, et al.Journal of Hepatocellular Carcinoma|January 19, 2024
First-Line Treatment for Advanced Hepatocellular Carcinoma: A Three-Armed Real-World ComparisonRobert Mahn, Oscar André Glüer, Farsaneh Sadeghlar, et al.British Journal of Haematology|March 19, 2016
Single versus tandem high-dose melphalan followed by autologous blood stem cell transplantation in multiple myeloma: long-term results from the phase III GMMG-HD2 trialElias K Mai, Axel Benner, Uta Bertsch, et al.Clinical Epigenetics|July 6, 2023
CTLA4 DNA methylation is associated with CTLA-4 expression and predicts response to immunotherapy in head and neck squamous cell carcinomaFriederike Hoffmann, Alina Franzen, Luka de Vos, et al.Frontiers in Oncology|December 3, 2021
First Line and Second Line Chemotherapy in Advanced Cholangiocarcinoma and Impact of Dose Reduction of Chemotherapy: A Retrospective AnalysisChristian Möhring, Jan Feder, Raphael U Mohr, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 18, 2019
Nivolumab Alone and With Ipilimumab in Previously Treated Metastatic Urothelial Carcinoma: CheckMate 032 Nivolumab 1 mg/kg Plus Ipilimumab 3 mg/kg Expansion Cohort ResultsPadmanee Sharma, Arlene Siefker-Radtke, Filippo de Braud, et al.Medicine|May 20, 2016
γ-Glutamyl Transferase Is an Independent Biomarker of Splanchnic Thrombosis in Patients With Myeloproliferative NeoplasmJan Görtzen, Lena M Hunka, Maria Vonnahme, et al.Pageof 27